- Fapon Biotech COVID-19 Testing Raw Materials Experimentally Proved to Be Effective on Omicron Variant Detection
(Mumbai, 20th May, 2022) Fapon Biotech is pleased to announce its attendance in the 27th edition of Medical Fair India, which is held from 20th - 22nd May 2022 at Jio world Convention Centre (JWCC), Mumbai. Medical Fair India is India’s leading exhibition and conference for clinics, hospitals and health centers, gathering over 400 exhibiting companies across the various segments from medical and healthcare vertical. Fapon Biotech’s booth locates at M02. Fapon Biotech has brought about its core raw materials, reagent solutions and open instrument platforms to Indian market. But more than that, the Company aims to empower local enterprises with its customized one-stop solutions in IVD industry.
Being dedicated to the IVD upstream raw materials filed for over 21 years, Fapon Biotech has established a comprehensive technology platform and formed a wide range of product lines. Meanwhile, to better serve our worldwide partners and community, the Company provides different level instruments with open system platform or OEM model, reagent development support, as well as high quality core raw material in bulk production. Together Fapon Biotech can localize the production in local market, to be your empowering partner of timely, accurate and affordable diagnosis solutions.
Fapon Biotech aims to overcome the difficulties for its global partners by providing affordable & quality IVD products, empowering independent medical development, and accelerating partners’ business development.
The demonstration of Fapon Biotech fully automatic CLIA Analyzers and molecular diagnostics analyzers was a big success during the exhibition. Visitors showed great interests in these robust instruments and the additional supporting services derived from the open systems.
In addition, Fapon Biotech’s raw materials and reagent development solutions aroused much interests from visitors and have been the hot sale products in Indian market, such as the reagent core raw materials testing COVID-19, Influenza A/B, infectious disease (HIV, HBV, HCV, TP), tropical disease (Dengue, Malaria, Mucormycosis), cardiac marker, tumor marker, inflammatory marker, and bone metabolic, as well as immunoturbidimetry reagent OEM solutions for HbA1c, CRP, ASO, RF, mALB, D-dimer, Ferritin, Anti CCP, etc. Fapon’s versatile COVID-19 diagnostic solutions utilize the most advanced molecular and immunodiagnostic technologies, encompassing Flu A/B + COVID-19 Ag/PCR test, antigen test, antibody test, neutralizing antibody test, RT-PCR test, and genomic sequencing of SARS-CoV-2. With the Omicron variant and its sub-variants having changed the dynamic of COVID-19 worldwide, testing is still relevant. Fapon Biotech, as one of the world's mainstream COVID-19 reagent raw materials and one-stop solution suppliers, has been devoted to combating SARS-CoV-2 ever since the outbreak. Fapon Biotech has provided thousands of grams of antibodies and antigens to global IVD companies, whose products have successfully achieved CE, FDA EUA, NMPA, ICMR, Anvisa, and other regulatory approvals.